6-Phosphogluconolactonase – Enzyme in Metabolism

What is 6-Phosphogluconolactonase?

6-Phosphogluconolactonase (abbreviated 6PGL) is an enzyme that plays a key role in the pentose phosphate pathway (also known as the hexose monophosphate shunt). This metabolic pathway is an important branch of carbohydrate metabolism and serves to produce NADPH (a high-energy reducing agent) and ribose-5-phosphate, which is required for the biosynthesis of nucleotides and nucleic acids.

The enzyme catalyzes the hydrolysis of 6-phospho-D-glucono-1,5-lactone to 6-phospho-D-gluconate. This reaction represents the second step of the oxidative branch of the pentose phosphate pathway and is essential for the smooth progression of this metabolic route.

Mechanism of Action

6-Phosphogluconolactonase belongs to the enzyme class of hydrolases. It accelerates a reaction that can also occur spontaneously, but would proceed very slowly without the enzyme. The catalytic mechanism involves the following steps:

• The substrate 6-phospho-D-glucono-1,5-lactone binds to the active site of the enzyme.
• The enzyme catalyzes the cleavage of the lactone bond through the addition of water (hydrolysis).
• The product 6-phospho-D-gluconate is released and becomes available as a substrate for the next enzyme in the pentose phosphate pathway, 6-phosphogluconate dehydrogenase.

The resulting product 6-phosphogluconate is further processed in the pentose phosphate pathway, ultimately yielding additional NADPH and ribose-5-phosphate.

Biological Significance

The pentose phosphate pathway, and therefore 6-phosphogluconolactonase, serves several important biological functions:

• Antioxidant protection: The NADPH produced is required to maintain glutathione in its reduced, active form. Glutathione protects cells against oxidative stress and reactive oxygen species (ROS).
• Nucleotide biosynthesis: Ribose-5-phosphate is a building block for the synthesis of DNA, RNA, and energy carriers such as ATP.
• Fatty acid synthesis: NADPH is also needed as a reducing agent in the synthesis of fatty acids and cholesterol.
• Red blood cell protection: In red blood cells (erythrocytes), the pentose phosphate pathway is especially important as it represents the sole source of NADPH in these cells.

Clinical Relevance

Disruptions in the pentose phosphate pathway, particularly deficiencies in its enzymes, can lead to clinically relevant diseases. A well-known example is glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency), which affects the first enzyme of the pathway and is the most common enzymopathic cause of hemolytic anemia worldwide.

Although an isolated deficiency of 6-phosphogluconolactonase in humans is rarely documented, the enzyme is actively studied in biochemical research. In certain pathogens such as Plasmodium falciparum (the causative agent of malaria), 6-phosphogluconolactonase is of interest as a potential drug target, since structural differences between the human and parasitic enzymes could be exploited to develop selective inhibitors.

Distribution and Genetics

6-Phosphogluconolactonase is found in virtually all living organisms, including humans, animals, plants, fungi, and microorganisms. In humans, the enzyme is encoded by the PGLS gene located on chromosome 19. It is active in essentially all tissues and cell types in which the pentose phosphate pathway operates.

References

1. Nelson, D. L. & Cox, M. M. (2021). Lehninger Principles of Biochemistry. W. H. Freeman and Company.
2. Stanton, R. C. (2012). Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life, 64(5), 362-369. PubMed PMID: 22431005.
3. World Health Organization (WHO). (2022). Glucose-6-phosphate dehydrogenase deficiency. WHO Report on Global Health.